Ben Shen, professor in the Pharmaceutical Sciences Division, received grants from American Recovery Act Funds to support his ongoing program on natural product biosynthesis, engineering, and drug discovery.
A Competitive Revision grant will expand Shen’s current effort on biosynthesis and engineering of the enediynes, some of the most potent anticancer drugs ever known. A Challenge Grant, for which Shen is a co-investigator and Bruce Klein, UW School of Medicine and Public Health, is the principal investigator, will explore natural products from under-explored microorganisms as novel antifungal drugs and drug leads.